Mashup Score:656
NatureAn early warning system for emerging SARS-CoV-2 variants – Nature Medicine - 1 week
Mashup Score:656
Twitter Feed: Amesh Adalja
Mashup Score:493
NatureMultisystem involvement is common in post-COVID-19 syndrome – Nature Medicine - 1 week
Mashup Score:493
A prospective clinical study evaluating patients 28–60 days after hospitalization for COVID-19 reveals increased cardio-renal inflammation, reduced lung function and poorer self-reported clinical outcomes...
-
Important to know that this study was in hospitalized patients and needs to be distinguished from general post-hospital and post-ICU syndrome vs long #COVID19 https://t.co/G1OQs758uR - view on twitter
More coverage:
#covid19
Mashup Score:332
ABC NewsFauci says he’s taking 2nd course of Paxlovid after experiencing rebound with the antiviral treatment - 17 hours
Mashup Score:332
Fauci, 81, said that when he first tested positive two weeks ago, he had very minimal...
-
I’m unclear as to the benefit of a 2nd course of Paxlovid in these types of situations — not really any data to guide this. Rebounds have all done well in case series. Important to study https://t.co/uaCazFdOvd - view on twitter
Mashup Score:312
NatureA multisystem, cardio-renal investigation of post-COVID-19 illness – Nature Medicine - 1 week
Mashup Score:312
Deep clinical phenotyping at 28–60 days post-discharge of patients who had been hospitalized with COVID-19 and subsequent long-term follow-up with electronic health records reveal evidence...
-
“The illness trajectory of patients after hospitalization with COVID-19 includes persisting multisystem abnormalities and health impairments” https://t.co/skjGMQ914j - view on twitter
Mashup Score:184
Slate MagazineShould Your Kids Get Moderna or Pfizer? - 1 week
Mashup Score:184
Yes, either is great. But if you could pick...
-
“the Pfizer data in particular had wide confidence intervals—basically, the efficacies are more like pretty good estimates than numbers that the scientists are really certain of” https://t.co/9Vzz3IU5AY - view on twitter
Mashup Score:61
STATU.S. Covid test makers anticipate layoffs after government reallocates funds - 1 week
Mashup Score:61
Covid-test makers and health officials alike said the need to trade off between testing and vaccines was dangerous, especially for a virus that is...
-
Need to prepare for a commercial market shift and get some sense of the demand for testing when it is not paid for by taxpayers https://t.co/AhAb1g2ac1 - view on twitter
Mashup Score:34
New York TimesBritain Declares National Incident After Poliovirus Found in London - 1 week
Mashup Score:34
No cases of polio have been identified so far, but health officials urged those who were not fully immunized to seek vaccines...
-
Really important and essential to note this is not wild polio, but circulating vaccine derived poliovirus (cVDPV). These vaccine strains will always be around so long as OPV (Sabin) is used and are a different problem than wild polio https://t.co/Q4fMpyVu1C - view on twitter
Mashup Score:29
POLITICODeSantis says Florida is ‘affirmatively against’ Covid-19 vaccines for young kids - 1 week
Mashup Score:29
“You are free to choose — that’s not the issue,” he also...
-
By this line of (non)thinking he would be against vaccines against rotavirus, chickenpox, meningococcus. It is just naked pandering and powerlust https://t.co/FhOSbiDvKX - view on twitter
Mashup Score:28
www.audacy.comHealth expert explains why ‘not everyone will benefit from Paxlovid’ - 2 days
Mashup Score:28
Despite the benefits of Paxlovid, health experts are explaining why the antiviral drug may not be the best choice for every COVID-19...
-
In this @KCBSRadio interview with @MelissaCulross I discuss the use of Paxlovid in high risk #COVID19 patients. https://t.co/jKlByB8etF - view on twitter
More coverage:
#covid19
Mashup Score:22
SalonEverything we know about Paxlovid, the COVID-treating pill - 1 week
Mashup Score:22
Experts explain how the drug works, where it came from, and what kinds of side effects to...
-
In this @nicolekarlis piece I’m quoted about various aspects of the #COVID19 antiviral Paxlovid https://t.co/5MdCDKYiPR - view on twitter
More coverage:
#covid19
Global sequencing and surveillance capacity for SARS-CoV-2 must be strengthened and combined with multidisciplinary studies of infectivity, virulence and immune escape, in order to...
“Given..challenges in predicting the evolution of the virus, targeted surveillance of suspected high-risk populations.. improving detection systems, such as a One Health approach, which also includes wastewater and animal surveillance, are critical” https://t.co/g5UAimPKNn - view on twitter